Abstract
IntroductionPatients with inflammatory bowel diseases (IBDs) frequently develop colon cancer. Previous studies have identified the association between IBD and colon cancer. In this study, we explored the characteristics and outcomes of IBD patients with colon cancer admitted to the hospitals of the United States.MethodsPatients who were hospitalized patients with diagnoses of IBD and colon cancer were compared with patients with IBD without colon cancer. The data were extracted from the Nationwide Inpatient Sample (NIS) from January 2016 to December 2017. Comparisons were made with regards to mortality, complications, in-hospital stay, and cost of treatment between the two groups.ResultsWe identified 1,82,025 hospitalizations from January 2016 to December 2017 admitted with a diagnosis of IBD. Of these, 181,560 patients had IBD without colon cancer, and 465 patients had IBD with colon cancer. No statistically significant difference was observed with regards to the in-hospital mortality between the two groups. There were higher odds of acute kidney injury (AKI) (OR 1.54, 95% CI 6.6-9.8; p=0.00), colectomy (OR 1.2, 95% CI 1.3-2.5; p=0.0) and lower gastrointestinal bleeding (LGIB) (OR 1.6, 95% CI 1.8-3.7; p=0.04) in patients with IBD and colon cancer. A longer length of stay (7.1±6.9 vs.5.0±5.6, p=0.00) and higher mean total charge ($20,283 vs. $12,166, p=0.00) were observed in patients with IBD with colon cancer.ConclusionsPatients with IBD-associated colon cancer appear to have higher complication rates, higher costs, and more extended hospital stays. Therefore, early identification and management of complications related to IBD among patients with colon cancer are particularly crucial to reduce morbidity as well as the cost of hospitalization and treatment.
Highlights
Patients with inflammatory bowel diseases (IBDs) frequently develop colon cancer
There were higher odds of acute kidney injury (AKI), colectomy and lower gastrointestinal bleeding (LGIB) in patients with IBD and colon cancer
Early identification and management of complications related to IBD among patients with colon cancer are crucial to reduce morbidity as well as the cost of hospitalization and treatment
Summary
In the present Nationwide Inpatient Sample (NIS) study, we aimed to assess the length of stay (LOS), hospital cost, morbidity, and mortality of patients with IBD and colon cancer in the United States
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have